Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of olanzapine on chemotherapy-induced nausea and vomiting
IRCT20170814035697N3Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Urmia University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on IRCT20170814035697N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170814035697N3.